The Virus Filtration Market is valued at USD 2.5 Billion in 2018 and is expected to reach USD 5.8 Billion by 2025 with a CAGR of 12.3% over the forecast period.
Growth in the Biopharmaceutical Industry and Adoption of Single-Use Technologies are the major factors that are contributing to the growth of the market.
The main use of Virus Filtration is for maintaining a pathogen such as bacteria, microbes and to make a virus-free environment. As the presence of pathogens in labs and biotechnology industries means there is the occurrence of contamination of water, air, and biotherapeutics. This safety of products and safety of the environment is maintained by this Virus Filtration. For holding the Virus particles, the Virus Filtration uses a Membrane Barrier. Virus Filtration is the removal method based on size which uses a specifically designed polymeric membrane to hold the Virus particles on the surface and within the pores of the membrane.
This Virus Filtration uses the membranes for obtaining virus clearance during the purification of biopharmaceutical products. There are four types of Virus Filtration Membranes used for Virus clearance as Retrovirus, Parvovirus, and two Ultrafiltration Membranes. In 1892 these filters come into use and it is first used by Dmitri Ivanovsky to show that sap from a diseased tobacco plant remained infectious to healthy tobacco plants despite having been filtered.
Virus filtration market is segmented on the basis of type and application. On the basis of type, the market is segmented into consumables, instruments, and services. On the basis of application, the market is segmented into biological, stem cell products, medical devices, water purification, and air purification.
The regions covered in this virus filtration market report are North America, Europe, Asia-Pacific, and the Rest of the World. On the basis of country level, the market of Hall Effect Sensor is subdivided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Globally Manufacturers such as,
Geographically, the Increase in applications in Biopharmaceutical Industries which include biological, medical devices, and purification technologies these are the main factors owing to the growth of the market. Also, the increasing prevalence of chronic diseases which include Cancer is fueling the market growth. According to the biopharmaceutical research industry profile, in the United States, there is a 23% decline in cancer deaths witnessed since the early 1990s into which about 1.5 million lives were saved.
Along with Cancer, many more diseases such as Diabetes and Autoimmune disorders are projected to drive the demand for biologics and this is the reason behind the increasing demand for therapeutic biologics which in turn significantly increases the demand for virus filtration products for R&D and manufacturing applications. The reagents such as sterile-filtering reagents are also contributing to the growth of the virus filtration market. These reagents help to reduce the potential of iatrogenic transmission of pathogenic viruses and they help to identify the virus that is likely to contaminate the cell-substrate or any other reagents or material used in the process.
North America is dominating the overall market and is expected to maintain its dominance for the forecast period of time due to the presence of well-established biotechnology and biopharmaceutical industries which are located in the U.S. region. According to the Pharmapproach estimated that the alone US holds over 45% of the global pharmaceutical market. Hence this is the main reason for encouraging the demand for advanced products for R&D and Biologics production in this region.
Moreover, Europe is the second most dominating region due to high demand for innovative virus filtration products for research and biologics developments and production and also the region has highly developed healthcare infrastructure and a large amount of money for R&D primarily in countries such as the U.K., Germany, and France contributing in the growth of the market. Along with these regions, the Asia Pacific is expected to contribute to the growth of the market. This is due to the region having a growing number of road accidents and trauma cases.
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Report Analysis | Details |
---|---|
Historical data | 2015 - 2020 |
Forecast Period | 2021 - 2027 |
Market Size in 2020: | USD 2.5 Billion |
Base year considered | 2020 |
Forecast Period CAGR %: |
12.30 % |
Market Size Expected in 2027: | USD 5.8 Billion |
Tables, Charts & Figures: | 175 |
Pages | 200 |
Virus Filtration Manufacturers | Asahi Kasei Medical Co. Ltd, Charles River Laboratories International Inc., General Electric Company, Lonza Group Ltd, Merck KgaA, Danaher Corporation (Pall Corporation), Sartorius AG, Clean Cell Inc., Thermo Fischer Scientific Inc., Wuxi Biologics |
Segments Covered | By Type, By Application |
Regional Analysis | North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa |
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®